Meeting
2022 ASCO Annual Meeting
Differential diagnosis of hematologic and solid tumors using targeted transcriptome and artificial intelligence.
Authors
Hong Zhang
Genomic Testing Cooperative, Irvine, CA
Hong Zhang , Maher Albitar , Muhammad Asif Qureshi , Mohsin Wahid , Ahmad Charifa , Aamir Ehsan , Andrew Ip , Ivan De Dios , Wanlong Ma , James McCloskey , Michele Donato , David Samuel DiCapua Siegel , Martin Gutierrez , Andrew L Pecora , Andre Goy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3018)
DOI
10.1200/JCO.2022.40.16_suppl.3018
Abstract #
3018
Poster Bd #
10
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Clinical application of novel mobile AI solution for real-time detection and differential diagnosis in breast ultrasound: The first prospective feasibility study.
First Author: Jeeyeon Lee
Poster
2024 ASCO Annual Meeting
Effect of combination of genomic variation–based machine learning and clinical pathology on accurate diagnosis of tumors: Lung adenocarcinoma and lung squamous cell carcinoma.
First Author: Weiguang Gu
Poster
2024 ASCO Annual Meeting
Using machine learning for targeted advance care planning (ACP) conversations in patients with cancer: A quality improvement initiative.
First Author: Mihir Patel
Poster
2024 ASCO Genitourinary Cancers Symposium
Advancing the drug development process in metastatic prostate cancer through machine learning.
First Author: David Alan Quigley